Hair Loss Prevalence in Izmit and Kocaeli: Regional Factors
Hair loss is significantly influenced not only by genetic predisposition, hormonal factors and stress, but also by environmental contributors. Individuals living in Izmit and the surrounding Kocaeli districts are exposed to certain additional risk factors compared to the national average in Turkey:
- Heavy metal exposure: Intake of heavy metals such as lead, cadmium and mercury via air and water from industrial facilities in Kocaeli may cause oxidative stress in hair follicles
- Air pollution: Chronic exposure to particulate matter (PM2.5) accumulation and organic pollutants such as polychlorinated biphenyls may adversely affect the course of androgenetic alopecia
- Occupational stress: The intense work pace in the industrial, logistics and manufacturing sectors can elevate cortisol levels and trigger telogen effluvium
- Dietary habits: Shift work patterns and high consumption of processed foods may negatively impact iron, ferritin, B12 and zinc levels — all critical for hair health
Given all these regional factors, it is critically important that hair loss assessment in Izmit residents be conducted from a holistic perspective that encompasses not only genetic and hormonal dimensions but also environmental ones.
Hair Assessment at Virtuana Clinic: Trichology Analysis
Accurate diagnosis before starting hair loss treatment is decisive for treatment selection and efficacy. The hair assessment process at Virtuana Clinic is comprehensive and multidimensional:
1. History and medical anamnesis: The onset and progression of shedding, family history, hormonal changes (pregnancy, menopause, thyroid disorders), medication use and stress factors are evaluated.
2. Blood test assessment: Ferritin (the most important parameter, ideally >70 ng/mL), complete blood count, thyroid hormones (TSH, T3, T4), iron, B12, folic acid, zinc and sex hormones (DHEA-S, testosterone, SHBG) are evaluated.
3. Trichology analysis: Examination of the scalp under 20–60× magnification via video dermoscopy; follicular density, miniaturization rate, number of hairs per follicular unit and overall scalp condition are assessed.
4. Phototrichology: High-resolution photographs taken under standardized lighting are archived as a pre-treatment reference and used for comparative evaluation after each session.
5. Pull test: A standardized pull test is applied to determine the active shedding phase.
Hair Treatment Options: PRP, Mesotherapy, Exosome and LLLT
Hair Loss PRP Treatment
Hair PRP harnesses the stimulatory effect of platelet growth factors on dermal papilla cells. PDGF (Platelet-Derived Growth Factor) and VEGF (Vascular Endothelial Growth Factor) increase blood circulation around the follicle, directing the hair cycle toward the anagen (growth) phase. Significant efficacy has been demonstrated in androgenetic alopecia — particularly at Norwood-Hamilton Grade I–III (male) and Ludwig I–II (female) classifications. Blood volume used per session is 18–27 mL; procedure duration is 30–40 minutes.
Hair Mesotherapy
Hair mesotherapy involves injecting specific vitamin and mineral complexes into the scalp level to nourish the follicle. The hair mesotherapy cocktail at Virtuana Clinic contains biotin (B7), panthenol (B5), zinc, copper peptide, cysteine, lysine, BHMT and growth factor complexes. Particularly in nutritional-deficiency-related hair loss, a noticeable reduction in shedding becomes apparent from the early weeks of treatment.
Exosome Hair Treatment
Exosomes are nano-sized vesicles secreted by cells, containing RNA, growth factors and signaling molecules. In hair loss treatment, exosomes contain a higher concentration of growth factors than PRP, carry no risk of allergic reaction and have a longer-lasting effect. They are considered a suitable alternative particularly in cases where an adequate response to PRP has not been achieved, or for patients with anemia.
LLLT (Low-Level Laser Therapy)
LLLT (Low-Level Laser Therapy) is a non-invasive technological treatment that increases mitochondrial activity and ATP production by delivering red and near-infrared light energy to the hair follicle. LLLT, which has received FDA indication approval for the treatment of hair loss, is applied at Virtuana Clinic in combination with PRP or mesotherapy. Patients who receive LLLT after sessions at the clinic show an accelerated rate of result onset.
Protocol Differences in Male-Pattern and Female-Pattern Hair Loss
| Parameter | Male Pattern (Androgenetic Alopecia) | Female Pattern (Diffuse / FPHL) |
|---|---|---|
| Loss pattern | Hairline recession + crown thinning | Diffuse thinning, widening part line |
| Primary trigger | DHT (dihydrotestosterone) sensitivity | Hormonal changes, deficiency, stress |
| Mesotherapy content | DHT blocker + growth factor dominant | Nutrition + hormonal balancer dominant |
| PRP frequency | Every 4 weeks (intensive phase) | Every 4–6 weeks |
| At-home supplement | 5% minoxidil foam / finasteride (physician-approved) | 2–5% minoxidil solution / biotin supplement |
| Hair transplant referral | Evaluation at NW Grade IV–VII | Evaluation at Ludwig III |
Treatment Schedule: Initial Intensive Phase and Maintenance Period
Hair loss treatment is planned in two fundamental phases:
Intensive initial phase (first 3–6 months): PRP or mesotherapy sessions are applied every 4 weeks. The goals during this phase are to stop shedding, reactivate miniaturized follicles and initiate new hair growth. In most patients, a reduction in shedding becomes apparent at weeks 6–8, and new hair emergence becomes visible at weeks 12–16.
Maintenance phase (from month 6 onward): After the intensive phase is completed, maintenance sessions are scheduled every 3–6 months to preserve the results achieved. The at-home care protocol (minoxidil, biotin, dietary support) and clinical treatment complement each other.
Hair Transplant Referral Criteria
While medical treatments are effective in slowing the progression of hair loss and preserving follicles, in advanced-stage alopecia (Norwood-Hamilton V–VII male, Ludwig III female) existing follicle loss is irreversible. In such cases, hair transplantation (FUE or DHI techniques) should be considered. The trichology assessment at Virtuana Clinic will include a referral to the relevant specialist center if the patient is a suitable hair transplant candidate. PRP/mesotherapy protocols applied before and after hair transplantation support graft retention and postoperative recovery.
At-Home Care Combination: Minoxidil and Biotin Protocol
When clinical treatment is supported by an at-home care protocol, results are noticeably strengthened. Recommended at-home care regimen for patients receiving hair loss treatment at Virtuana Clinic:
- Minoxidil: 5% foam for men (once daily, morning application), 2% or 5% solution for women (twice daily); a temporary increase in shedding during the first 4–8 weeks is normal — it is important not to discontinue treatment
- Oral biotin (vitamin B7): 2,500–5,000 mcg daily; its contribution to hair thickness is limited in the absence of a deficiency, but it benefits nail and skin health
- Dietary support: A diet rich in 60–80 g protein per day, 8 mg iron (18 mg for women), zinc, omega-3 and B12
- Shampoo selection: Shampoos containing ketoconazole or zinc pyrithione can be used 2–3 times per week for scalp health and anti-inflammatory effect
- Stress management: Given that chronic stress in Izmit's demanding work environment can trigger telogen effluvium via cortisol, stress-reduction strategies (sleep hygiene, exercise) are an integral part of treatment
Appointment and Assessment
The correct first step to beginning hair loss treatment is a comprehensive trichology assessment. At Virtuana Clinic Izmit, this assessment is conducted free of charge; blood test interpretation, dermoscopy findings and a personalized treatment plan are provided to the patient as the consultation output. Appointments can be booked online via the website. Patients are welcomed from Izmit city center and all districts of Kocaeli.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.